P. Sourdeau, J. Evrard, R. G. Hecq, and J. , Stabilit?? physico-chimique de solutions ophtalmiques renforc??es pr??tes ?? l???emploi??: une revue de la litt??rature, Annales Pharmaceutiques Fran??aises, vol.70, issue.2, pp.2012104-2012116
DOI : 10.1016/j.pharma.2011.11.005

. Afssaps, Bonnes pratiques de préparation. JORF, Consulté sur, 2007.

L. Hir, A. Cohen, and Y. , Pharmacie galénique: bonnes pratiques de fabrication des médicaments, 2001.

P. Wehrlé, Pharmacie galénique: formulation et technologie pharmaceutique, 2012.

C. Teping and B. Wiedemann, Das COMOD??-System - Ein konservierungsmittelfreies Mehrdosenbeh??ltnis f??r Augentropfen, Klinische Monatsbl??tter f??r Augenheilkunde, vol.205, issue.10, pp.210-217, 1994.
DOI : 10.1055/s-2008-1045518

D. Sirbat, L. Marchal-heussler, M. Hoffman, and P. Maincent, Moyens d'amélioration de la biodisponibilité pour la voie topique, J Fr Ophtalmol, vol.23, issue.523, pp.505-509, 2000.

V. Chédru-legros, M. Fines-guyon, A. Chérel, A. Perdriel, F. Albessard et al., Stabilit?? ?? ??? 20??C des collyres antibiotiques renforc??s (amikacine, ceftazidime, vancomycine), Journal Fran??ais d'Ophtalmologie, vol.30, issue.8, pp.807-820, 2007.
DOI : 10.1016/S0181-5512(07)92614-5

A. Mcnab, Lacrimal canalicular obstruction associated with topical ocular medication, Australian and New Zealand Journal of Ophthalmology, vol.112, issue.3
DOI : 10.1111/j.1442-9071.1998.tb01315.x

L. Trissel, Handbook on injectable drugs, 2011.

M. Husson, Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67

J. Hecq, Centralized intravenous additive services (CIVAS): the state of the art in, 2010.

N. El-tayar, A. Mark, P. Vallat, R. Brunne, B. Testa et al., Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations, Journal of Medicinal Chemistry, vol.36, issue.24, pp.3757-64, 1993.
DOI : 10.1021/jm00076a002

S. Mithani, V. Bakatselou, C. Tenhoor, and J. Dressman, Estimation of the increase in solubility of drugs as a function of bile salt concentration, Pharmaceutical Research, vol.13, issue.1, pp.163-170, 1996.
DOI : 10.1023/A:1016062224568

F. Chast, F. Lemare, J. Legeais, R. Batista, C. Bardin et al., Pr??paration d???un collyre de ciclosporine ?? 2 %, Journal Fran??ais d'Ophtalmologie, vol.27, issue.6, pp.567-76, 2004.
DOI : 10.1016/S0181-5512(04)96181-5

F. Beby, C. Burillon, G. Putet, and P. Denis, R??tinopathie du pr??matur?? : r??sultats de l???examen du fond d?????il chez 94 enfants ?? risque, Journal Fran??ais d'Ophtalmologie, vol.27, issue.4, pp.337-381, 2004.
DOI : 10.1016/S0181-5512(04)96138-4

M. Baron-janaillac, F. Cneude, F. Bavoux, P. Cornali, V. Jobert et al., Les collyres mydriatiques sont-ils dangereux chez le nouveau-né prématuré? Arch Pediatr, pp.299-302, 2011.

L. Willems, K. Allegaert, and I. Casteels, Prospective assessment of systemic side effects of topical ophthalmic drug administration for screening for retinopathy of prematurity, Paediatric and Perinatal Drug Therapy, vol.7, issue.3, 2006.
DOI : 10.1185/146300906X112890

B. Bolt, B. Benz, F. Koerner, and E. Bossi, A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study, J Pediatr Ophthalmol Strabismus, vol.29, issue.3, pp.157-62, 1992.

B. Fleck, B. Dhillon, and A. Mitchell, Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies, J Pediatr Ophthalmol Strabismus avr, vol.31, issue.2, p.130, 1994.

M. O?üt, N. Bozkurt, E. Ozek, H. Birgen, H. Kazoko?lú et al., Effects and side effects of mydriatic eyedrops in neonates, Eur J Ophthalmol, vol.6, issue.2, pp.192-198, 1996.

C. Chew, R. Rahman, S. Shafie, and M. Z. , Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides, J Pediatr Ophthalmol Strabismus, vol.42, issue.3, pp.166-73, 2005.

A. Punyawattanaporn, S. Tengtrisorn, and P. Sangsupawanich, Pupil dilatation after single and triple doses of mydriatic agent in preterm infants, J Med Assoc Thai nov, vol.92, issue.11, pp.1458-62, 2009.

M. Elsayed, A. Obiakara, and S. Uzodinma, Bromination methods for determination of phenylephrine hydrochloride in nose drops, salicylamide in tablets, and tetracycline hydrochloride in capsules, J Assoc Off Anal Chem. juill, vol.64, issue.4, pp.860-863, 1981.

S. Shama, Spectrophotometric determination of phenylephrine HCl and orphenadrine citrate in pure and in dosage forms, Journal of Pharmaceutical and Biomedical Analysis, vol.30, issue.4, pp.1385-92, 2002.
DOI : 10.1016/S0731-7085(02)00437-5

M. Knochen and J. Giglio, Flow-injection determination of phenylephrine hydrochloride in pharmaceutical dosage forms with on-line solid-phase extraction and spectrophotometric detection. Talanta, déc, vol.1564, issue.5, pp.1226-1258, 2004.

N. Erk, Quantitative analysis of chlorpheniramine maleate and phenylephrine hydrochloride in nasal drops by differential-derivative spectrophotometric, zero-crossing first derivative UV spectrophotometric and absorbance ratio methods, Journal of Pharmaceutical and Biomedical Analysis, vol.23, issue.6, pp.1023-1054, 2000.
DOI : 10.1016/S0731-7085(00)00371-X

M. Galmier, A. Frasey, S. Meski, E. Beyssac, J. Petit et al., High-performance liquid chromatographic determination of phenylephrine and tropicamide in human aqueous humor, Biomedical Chromatography, vol.661, issue.3, pp.202-206, 2000.
DOI : 10.1002/1099-0801(200005)14:3<202::AID-BMC943>3.0.CO;2-7

B. Olmo, A. García, A. Marín, and C. Barbas, New approaches with two cyano columns to the separation of acetaminophen, phenylephrine, chlorpheniramine and related compounds, Journal of Chromatography B, vol.817, issue.2, pp.159-65, 2005.
DOI : 10.1016/j.jchromb.2004.11.060

M. Dou?a, P. Gibala, J. Havlí?ek, L. Pla?ek, M. Tkadlecová et al., Drug-excipient compatibility testing???Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold, Journal of Pharmaceutical and Biomedical Analysis, vol.55, issue.5, pp.949-56, 2011.
DOI : 10.1016/j.jpba.2011.03.027

C. Botelho, J. Rodrigues, C. Branco, and M. , Allergic contact blepheroconjunctivitis with phenylephrine eyedrops ???the relevance of late readings of intradermal tests, Allergologia et Immunopathologia, vol.35, issue.4, pp.157-165, 2007.
DOI : 10.1157/13108227

E. Calenda, F. Richez, and M. Muraine, Acute hypertension due to phenylephrine eyedrops in a newborn, Canadian Journal of Ophthalmology, vol.42, issue.3, p.486, 2007.
DOI : 10.3129/i07-060

K. Shinomiya, M. Kajima, H. Tajika, H. Shiota, R. Nakagawa et al., Renal failure caused by eyedrops containing phenylephrine in a case of retinopathy of prematurity, J. Med. Invest, vol.50, pp.3-4203, 2003.

F. Blandin and J. Université, Le chlorhydrate de phényléphrine activité, étude des produits de dégradation, stabilité selon la nature du conditionnement

L. Trissel, Handbook on injectable drugs, 2011.

F. Luduena, A. Snyder, and A. Lands, EFFECT OF ULTRA-VIOLET IRRADIATION OF PHENYLEPHRINE SOLUTIONS, Journal of Pharmacy and Pharmacology, vol.12, issue.1, pp.538-581, 1963.
DOI : 10.1111/j.2042-7158.1963.tb12830.x

B. Millard, D. Priaulx, and E. Shotton, The stability of aqueous solutions of phenylephrine at elevated temperatures: identification of the decomposition products, J. Pharm. Pharmacol. déc, vol.25, pp.24-31, 1973.

L. Chafetz and L. Chow, Photochemical hydroxylation of phenylephrine to epinephrine (adrenaline), Journal of Pharmaceutical and Biomedical Analysis, vol.6, issue.5, pp.511-515, 1988.
DOI : 10.1016/0731-7085(88)80018-9

. Afssaps, Liste des Excipients à Effet Notoire, Consulté sur, 2009.

. Afssaps, Décision du 12 mars 2010 portant inscription au répertoire des groupes génériques mentionné à l'article R. 5121-5 du code de la santé publique. [cité le 19 juillet 2012]; Consulté sur: ansm

R. Rowe, P. Sheskey, and M. Quinn, Handbook of pharmaceutical excipients. London; Chicago, 2009.

C. Chiquet and J. Romanet, Prescrire les collyres fortifi??s, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.423-453, 2007.
DOI : 10.1016/S0181-5512(07)89618-5

A. Darugar, T. Gaujoux, P. Goldschmidt, C. Chaumeil, L. Laroche et al., Caract??ristiques cliniques, microbiologiques et th??rapeutiques d???une s??rie de 111??k??ratites bact??riennes s??v??res, Journal Fran??ais d'Ophtalmologie, vol.34, issue.6, pp.362-370, 2011.
DOI : 10.1016/j.jfo.2010.12.003

N. Mesplié, J. Kérautret, S. Léoni, V. Dubois, and C. J. , K??ratites bact??riennes s??v??res et sensibilit?? des germes aux fluoroquinolones, Journal Fran??ais d'Ophtalmologie, vol.32, issue.4, pp.273-279, 2009.
DOI : 10.1016/j.jfo.2008.12.002

P. Lafontaine, A. Bron, and C. Creuzot-garcher, ??tude prospective sur les endophtalmies aigu??s postop??ratoires, Journal Fran??ais d'Ophtalmologie, vol.28, issue.2, pp.135-183, 2005.
DOI : 10.1016/S0181-5512(05)81036-8

J. Kerautret, L. Raobela, and C. J. , K??ratites bact??riennes s??v??res: ??tude r??trospective clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.29, issue.8, pp.883-891, 2006.
DOI : 10.1016/S0181-5512(06)70108-5

T. Bourcier, F. Thomas, V. Borderie, C. Chaumeil, and L. Laroche, Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases, British Journal of Ophthalmology, vol.87, issue.7, pp.834-842, 2003.
DOI : 10.1136/bjo.87.7.834

. Afssaps, Collyres et autres topiques antibiotiques dans les infections oculaires superficielles, 2004.

J. Guzek, D. Cline, P. Row, I. Wessels, S. Beeve et al., Rabbit Streptococcus pneumoniae keratitis model and topical therapy, Invest. Ophthalmol. Vis. Sci. oct, vol.39, issue.11, pp.2012-2019, 1998.

O. Galvez, J. Mullot, H. Mullot, L. Simon, R. Grippi et al., Étude de stabilité d'un collyre à 6 mg/mL de ticarcilline. Le Pharmacien Hospitalier et Clinicien, déc, vol.42, issue.171, pp.171-177, 2007.

S. Blondeel, A. Pelloquin, A. Pointereau-bellanger, A. Thuillier, and C. Fernandez, Effect of freezing on stability of a fortified 5 mg/mL ticarcillin ophthalmic solution. Can J Hosp Pham, avr, vol.58, issue.2, pp.65-70, 2005.

V. Shull and J. Dick, Determination of ticarcillin levels in serum by high-pressure liquid chromatography., Antimicrobial Agents and Chemotherapy, vol.28, issue.5, pp.597-600, 1985.
DOI : 10.1128/AAC.28.5.597

Z. Zhu, D. Xuan, and C. Nightingale, Modification of an ion-paired high pressure liquid chromatography for ticarcillin in human serum, sept, vol.17, issue.5, pp.395-403, 1996.

L. Lez, M. Lanotte, P. Arsene, S. Arbeille, B. Pisella et al., Endophtalmies postop??ratoires ?? Enterococcus faecalis, Journal Fran??ais d'Ophtalmologie, vol.27, issue.3, pp.271-278, 2004.
DOI : 10.1016/S0181-5512(04)96130-X

T. Heigle and G. Peyman, Retinal toxicity of intravitreal ticarcillin. Ophthalmic Surg, pp.563-568, 1990.

C. Roth, Fiche de données de sécurité de la ticarcilline. [cité le 12 août 2012, Consulté sur

E. Nicholas, G. Hess, and H. Colten, Degradation of penicillin, ticarcillin, and carbenicillin resulting from storage of unit doses, N. Engl. J. Med. 1982 mars, vol.4306, issue.9, pp.547-555

C. Chiquet and J. Romanet, Prescrire les collyres fortifi??s, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.423-453, 2007.
DOI : 10.1016/S0181-5512(07)89618-5

A. Darugar, T. Gaujoux, P. Goldschmidt, C. Chaumeil, L. Laroche et al., Caract??ristiques cliniques, microbiologiques et th??rapeutiques d???une s??rie de 111??k??ratites bact??riennes s??v??res, Journal Fran??ais d'Ophtalmologie, vol.34, issue.6, pp.362-370, 2011.
DOI : 10.1016/j.jfo.2010.12.003

N. Mesplié, J. Kérautret, S. Léoni, V. Dubois, and C. J. , K??ratites bact??riennes s??v??res et sensibilit?? des germes aux fluoroquinolones, Journal Fran??ais d'Ophtalmologie, vol.32, issue.4, pp.273-279, 2009.
DOI : 10.1016/j.jfo.2008.12.002

P. Lafontaine, A. Bron, and C. Creuzot-garcher, ??tude prospective sur les endophtalmies aigu??s postop??ratoires, Journal Fran??ais d'Ophtalmologie, vol.28, issue.2, pp.135-183, 2005.
DOI : 10.1016/S0181-5512(05)81036-8

J. Kerautret, L. Raobela, and C. J. , K??ratites bact??riennes s??v??res: ??tude r??trospective clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.29, issue.8, pp.883-891, 2006.
DOI : 10.1016/S0181-5512(06)70108-5

T. Bourcier, F. Thomas, V. Borderie, C. Chaumeil, and L. Laroche, Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases, British Journal of Ophthalmology, vol.87, issue.7, pp.834-842, 2003.
DOI : 10.1136/bjo.87.7.834

. Afssaps, Collyres et autres topiques antibiotiques dans les infections oculaires superficielles, 2004.

J. Guzek, D. Cline, P. Row, I. Wessels, S. Beeve et al., Rabbit Streptococcus pneumoniae keratitis model and topical therapy, Invest. Ophthalmol. Vis. Sci. oct, vol.39, issue.11, pp.2012-2019, 1998.

M. Husson, Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67

J. Lomholt, J. Møller, and N. Ehlers, Prolonged persistence on the ocular surface of fortified gentamicin ointment as compared to fortified gentamicin eye drops, Acta Ophthalmologica Scandinavica, vol.78, issue.1, pp.34-40, 2000.
DOI : 10.1034/j.1600-0420.2000.078001034.x

L. Lez, M. Lanotte, P. Arsene, S. Arbeille, B. Pisella et al., Endophtalmies postop??ratoires ?? Enterococcus faecalis, Journal Fran??ais d'Ophtalmologie, vol.27, issue.3, pp.271-278, 2004.
DOI : 10.1016/S0181-5512(04)96130-X

E. Ancele, L. Lequeux, P. Fournié, E. Chapotot, J. Douat et al., K??ratites bact??riennes s??v??res. ??tude ??pid??miologique, clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.32, issue.8, pp.558-65, 2009.
DOI : 10.1016/j.jfo.2009.04.013

L. Soltés, Aminoglycoside antibiotics ??? two decades of their hplc bioanalysis, Biomedical Chromatography, vol.231, issue.1, pp.3-10, 1999.
DOI : 10.1002/(SICI)1099-0801(199902)13:1<3::AID-BMC811>3.0.CO;2-T

P. Ho, H. Soh, S. Lim, and K. Yow, Stability of Extemporaneously Prepared Gentamicin Ophthalmic Solutions, Annals of Pharmacotherapy, vol.27, issue.10, pp.1293-1297, 2001.
DOI : 10.1345/aph.19026

H. Mcbride, D. Martinez, J. Trang, R. Lander, and H. Helms, Stability of gentamicin sulfate and tobramycin sulfate in extemporaneously prepared ophthalmic solutions at 8 degrees C, Am J Hosp Pharm, vol.48, issue.3, pp.507-516, 1991.

H. Curiel, W. Vanderaerden, H. Velez, J. Hoogmartens, V. Schepdael et al., Analysis of underivatized gentamicin by capillary electrophoresis with UV detection, Journal of Pharmaceutical and Biomedical Analysis, vol.44, issue.1, pp.49-56, 2007.
DOI : 10.1016/j.jpba.2007.01.029

C. Lipener and A. Ribeiro, Bilateral Pseudomonas corneal ulcer in a disposable contact lens wearer, CLAO J. avr, vol.25, issue.2, pp.123-127, 1999.

C. Ponchel, F. Malecaze, J. Arne, and P. Fournie, 384 K??ratite ?? Nocardia abscessus : ?? propos d???un cas, Journal Fran??ais d'Ophtalmologie, vol.32, issue.0, pp.1-123, 2009.
DOI : 10.1016/S0181-5512(09)73508-9

C. Tan, P. Krishnan, F. Foo, J. Pan, and L. Voon, Neisseria meningitidis keratitis in adults: a case series, Ann. Acad. Med. Singap. nov, vol.35, issue.11, pp.837-846, 2006.

R. Tang and R. Tse, Acute Renal Failure After Topical Fortified Gentamicin and Vancomycin Eyedrops, Journal of Ocular Pharmacology and Therapeutics, vol.27, issue.4, pp.411-414, 2011.
DOI : 10.1089/jop.2010.0163

L. Trissel, Handbook on injectable drugs, 2011.

M. Dicicco, T. Duong, A. Chu, and S. Jansen, Tobramycin and Gentamycin elution analysis between two in situ polymerizable orthopedic composites, Journal of Biomedical Materials Research, vol.4, issue.1, pp.137-186, 2003.
DOI : 10.1002/jbm.b.10528

D. Vaede, C. Baudouin, J. Warnet, and F. Brignole-baudouin, Les conservateurs des collyres??: vers une prise de conscience de leur toxicit??, Journal Fran??ais d'Ophtalmologie, vol.33, issue.7, pp.505-529, 2010.
DOI : 10.1016/j.jfo.2010.06.018

C. Seitz, E. Bröcker, and A. Trautmann, Eyelid dermatitis due to sodium metabisulfite. Contact Derm, oct, vol.55, issue.4, pp.249-50, 2006.

H. Nagayama, A. Hatamochi, and H. Shinkai, A Case of Contact Dermatitis Due to Sodium Bisulfite in an Ophthalmic Solution, The Journal of Dermatology, vol.38, issue.10, pp.675-682, 1997.
DOI : 10.1111/j.1346-8138.1997.tb02315.x

G. Oldham and V. Andrews, Control of microbial contamination in unpreserved eyedrops., British Journal of Ophthalmology, vol.80, issue.7, pp.588-91, 1996.
DOI : 10.1136/bjo.80.7.588

C. Lin and M. Boehnke, Effect of Fortified Antibiotic Solutions on Corneal Epithelial Wound Healing, Cornea, vol.19, issue.2, pp.204-210, 2000.
DOI : 10.1097/00003226-200003000-00014

C. Davison, S. Tuft, and J. Dart, Conjunctival Necrosis After Administration of Topical Fortified Aminoglycosides, American Journal of Ophthalmology, vol.111, issue.6, pp.690-693, 1991.
DOI : 10.1016/S0002-9394(14)76771-6

B. Weston and J. Loveless, Canalicular stenosis due to topical use of fortified antibiotics, Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie, vol.35, issue.6, pp.334-339, 2000.
DOI : 10.1016/S0008-4182(00)80062-9

R. Rowe, P. Sheskey, and M. Quinn, Handbook of pharmaceutical excipients. London; Chicago, 2009.

S. Epstein, M. Ahdoot, E. Marcus, and P. Asbell, Comparative Toxicity of Preservatives on Immortalized Corneal and Conjunctival Epithelial Cells, Journal of Ocular Pharmacology and Therapeutics, vol.25, issue.2, pp.113-122, 2009.
DOI : 10.1089/jop.2008.0098

C. Chiquet and J. Romanet, Prescrire les collyres fortifi??s, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.423-453, 2007.
DOI : 10.1016/S0181-5512(07)89618-5

A. Darugar, T. Gaujoux, P. Goldschmidt, C. Chaumeil, L. Laroche et al., Caract??ristiques cliniques, microbiologiques et th??rapeutiques d???une s??rie de 111??k??ratites bact??riennes s??v??res, Journal Fran??ais d'Ophtalmologie, vol.34, issue.6, pp.362-370, 2011.
DOI : 10.1016/j.jfo.2010.12.003

N. Mesplié, J. Kérautret, S. Léoni, V. Dubois, and C. J. , K??ratites bact??riennes s??v??res et sensibilit?? des germes aux fluoroquinolones, Journal Fran??ais d'Ophtalmologie, vol.32, issue.4, pp.273-279, 2009.
DOI : 10.1016/j.jfo.2008.12.002

P. Lafontaine, A. Bron, and C. Creuzot-garcher, ??tude prospective sur les endophtalmies aigu??s postop??ratoires, Journal Fran??ais d'Ophtalmologie, vol.28, issue.2, pp.135-183, 2005.
DOI : 10.1016/S0181-5512(05)81036-8

J. Kerautret, L. Raobela, and C. J. , K??ratites bact??riennes s??v??res: ??tude r??trospective clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.29, issue.8, pp.883-891, 2006.
DOI : 10.1016/S0181-5512(06)70108-5

T. Bourcier, F. Thomas, V. Borderie, C. Chaumeil, and L. Laroche, Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases, British Journal of Ophthalmology, vol.87, issue.7, pp.834-842, 2003.
DOI : 10.1136/bjo.87.7.834

. Afssaps, Collyres et autres topiques antibiotiques dans les infections oculaires superficielles, 2004.

J. Guzek, D. Cline, P. Row, I. Wessels, S. Beeve et al., Rabbit Streptococcus pneumoniae keratitis model and topical therapy, Invest. Ophthalmol. Vis. Sci. oct, vol.39, issue.11, pp.2012-2019, 1998.

L. Trissel, Handbook on injectable drugs, 2011.

. Sciencelab, Fiche de données de sécurité de la vancomycine chlorhydrate, Consulté sur

M. Husson, Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67

L. Lez, M. Lanotte, P. Arsene, S. Arbeille, B. Pisella et al., Endophtalmies postop??ratoires ?? Enterococcus faecalis, Journal Fran??ais d'Ophtalmologie, vol.27, issue.3, pp.271-278, 2004.
DOI : 10.1016/S0181-5512(04)96130-X

E. Ancele, L. Lequeux, P. Fournié, E. Chapotot, J. Douat et al., K??ratites bact??riennes s??v??res. ??tude ??pid??miologique, clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.32, issue.8, pp.558-65, 2009.
DOI : 10.1016/j.jfo.2009.04.013

V. Chédru-legros, M. Fines-guyon, A. Chérel, A. Perdriel, F. Albessard et al., Stabilit?? ?? ??? 20??C des collyres antibiotiques renforc??s (amikacine, ceftazidime, vancomycine), Journal Fran??ais d'Ophtalmologie, vol.30, issue.8, pp.807-820, 2007.
DOI : 10.1016/S0181-5512(07)92614-5

M. Itoh, T. Aoyama, A. Iemoto, K. Nakajima, S. Amano et al., Pharmaceutical Investigation of Vancomycin Hydrochloride Eye Drops and Their Topical Application to MRSA Eye Infection, YAKUGAKU ZASSHI, vol.121, issue.6, pp.433-442, 2001.
DOI : 10.1248/yakushi.121.433

V. Sautou-miranda, F. Libert, A. Grand-boyer, C. Gellis, and J. Chopineau, Impact of deep freezing on the stability of 25 mg/ml vancomycin ophthalmic solutions, International Journal of Pharmaceutics, vol.234, issue.1-2, pp.205-217, 20022.
DOI : 10.1016/S0378-5173(01)00961-9

D. Gupta, V. Stewart, K. Nohria, and S. , Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections, Am J Hosp Pharm juill, vol.43, issue.7, pp.1729-1760, 1986.

A. Kwok, M. Hui, C. Pang, R. Chan, S. Cheung et al., An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis, Invest. Ophthalmol. Vis. Sci. avr, vol.43, issue.4, pp.1182-1190, 2002.

M. Balikoglu-yilmaz, T. Yilmaz, A. Esen, K. Engin, and M. Taskapili, Pasteurella canis and Granulicatella adiacens Conjunctivitis Outbreak Resistant to Empirical Treatment in a Child Welfare Agency, Journal of pediatric ophthalmology and strabismus juill, pp.1-6, 2012.

G. Galperín, G. Boscaro, J. Tau, and M. Berra, Crystalline keratopathy: an infrequent corneal infection produced by the Streptococcus mitis group, Rev. Argent. Microbiol. sept, vol.43, issue.3, pp.195-202, 2011.

R. Tang and R. Tse, Acute Renal Failure After Topical Fortified Gentamicin and Vancomycin Eyedrops, Journal of Ocular Pharmacology and Therapeutics, vol.27, issue.4, pp.411-414, 2011.
DOI : 10.1089/jop.2010.0163

J. Hwu, K. Chen, W. Hsu, J. Lai, and Y. Li, Ocular Hypersensitivitiy to Topical Vancomycin in a Case of Chronic Endophthalmitis, Cornea, vol.24, issue.6, pp.754-760, 2005.
DOI : 10.1097/01.ico.0000154386.43732.b5

H. Borhani, G. Peyman, and H. Wafapoor, Use of vancomycin in vitrectomy infusion solution and evaluation of retinal toxicity, International Ophthalmology, vol.66, issue.2, pp.85-93, 1993.
DOI : 10.1007/BF00942780

M. Cahane, B. Simon, G. Barequet, I. Grinbaum, A. Diamanstein-weiss et al., Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin, British Journal of Ophthalmology, vol.88, issue.1, pp.22-26, 2004.
DOI : 10.1136/bjo.88.1.22

F. Marshall, Structure Studies on Vancomycin, Journal of Medicinal Chemistry, vol.8, issue.1, pp.18-22, 1965.
DOI : 10.1021/jm00325a004

S. Barbault, G. Aymard, D. Feldman, A. Pointereau-bellanger, and A. Thuillier, Etude de stabilité d'un collyre à la vancomycine à 50mg/mL, J Pharm Clin, vol.18, issue.2, pp.183-192, 1999.

V. Chédru-legros, M. Fines-guyon, A. Chérel, A. Perdriel, F. Albessard et al., In Vitro Stability of Fortified Ophthalmic Antibiotics Stored at ???20??C for 6 Months, Cornea, vol.29, issue.7, pp.807-818, 2010.
DOI : 10.1097/ICO.0b013e3181c32573

M. Wood, R. Lund, and M. Beavan, Stability of vancomycin in plastic syringes measured by high???performance liquid chromatography, Journal of Clinical Pharmacy and Therapeutics, vol.4, issue.5, pp.319-344, 1995.
DOI : 10.1021/jm00325a004

T. Bourcier and C. Chaumeil, Prescrire les collyres antifongiques et antiamibiens, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.431-436, 2007.
DOI : 10.1016/S0181-5512(07)89619-7

W. Behrens-baumann, Keratomycosis: diagnosis and therapy, Der Ophthalmologe, vol.776, issue.5, pp.471-480, 2009.
DOI : 10.1007/s00347-009-1925-1

T. Bourcier, A. Sauer, V. Letscher-bru, and E. Candolfi, K??ratites fongiques, Journal Fran??ais d'Ophtalmologie, vol.34, issue.8, pp.563-570, 2011.
DOI : 10.1016/j.jfo.2011.03.001

N. Rondeau, T. Bourcier, C. Chaumeil, V. Borderie, O. Touzeau et al., Kératites fongiques au Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts: étude rétrospective sur 19 cas, J Fr Ophtalmol nov, vol.25, issue.9, pp.890-896, 2002.

M. Tanure, E. Cohen, S. Sudesh, C. Rapuano, and P. Laibson, Spectrum of Fungal Keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania, Cornea, vol.19, issue.3, pp.307-319, 2000.
DOI : 10.1097/00003226-200005000-00010

J. Cannon, R. Fiscella, S. Pattharachayakul, K. Garey, D. Alba et al., Comparative Toxicity and Concentrations of Intravitreal Amphotericin B Formulations in a Rabbit Model, Investigative Opthalmology & Visual Science, vol.44, issue.5
DOI : 10.1167/iovs.02-1020

K. Morand, A. Bartoletti, A. Bochot, G. Barratt, M. Brandely et al., Liposomal amphotericin B eye drops to treat fungal keratitis: Physico-chemical and formulation stability, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.150-153, 2007.
DOI : 10.1016/j.ijpharm.2007.04.028

M. Husson, Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67

P. Egger, R. Bellmann, and C. Wiedermann, Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, vol.760, issue.2
DOI : 10.1016/S0378-4347(01)00292-4

A. Alak, S. Moy, and I. Bekersky, A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation. Ther Drug Monit, oct, vol.18, issue.5, pp.604-613, 1996.

T. Eldem and N. Arican-cellat, High-Performance Liquid Chromatographic Determination of Amphotericin B in a Liposomal Pharmaceutical Product and Validation of the Assay, Journal of Chromatographic Science, vol.38, issue.8, pp.338-382, 2000.
DOI : 10.1093/chromsci/38.8.338

G. Touvron, D. Denis, M. Doat, A. Girard, M. Brandely et al., Efficacit?? de l???amphot??ricine??B liposomale dans le traitement d???une k??ratite ?? Fusarium solani r??sistante, Journal Fran??ais d'Ophtalmologie, vol.32, issue.10, pp.721-727, 2009.
DOI : 10.1016/j.jfo.2009.10.011

D. Goldblum, B. Frueh, S. Zimmerli, and M. Böhnke, Treatment of Postkeratitis Fusarium Endophthalmitis with Amphotericin B Lipid Complex, Cornea, vol.19, issue.6, pp.853-859, 2000.
DOI : 10.1097/00003226-200011000-00019

W. Chen, Y. Tsai, J. Lin, and C. Chiang, Unilateral Candida parapsilosis Interface Keratitis After Laser In Situ Keratomileusis-Case Report and Review of the Literature, Cornea, vol.28, issue.1, pp.105-112, 2009.
DOI : 10.1097/ICO.0b013e318184e69b

H. Nascimento, L. Oliveira, . De, and A. Höfling-lima, Infectious keratitis in patients undergoing Boston Type 1 keratoprosthesis (Boston KPro) procedure: case series, Arquivos Brasileiros de Oftalmologia, vol.74, issue.2, pp.127-136, 2011.
DOI : 10.1590/S0004-27492011000200012

T. Wood and W. Williford, Treatment of Keratomycosis with Amphotericin B 0.15%, American Journal of Ophthalmology, vol.81, issue.6, pp.847-856, 1976.
DOI : 10.1016/0002-9394(76)90369-X

D. Jones, R. Sexton, and G. Rebell, Mycotic keratitis in South Florida: a review of thirty-nine cases, Trans Ophthalmol Soc U K, vol.89, pp.781-97, 1970.

B. Anderson, . Jr, and E. Chick, Mycokeratitis: Treatment of Fungal Corneal Ulcers with Amphotericin B and Mechanical Debridement, Southern Medical Journal, vol.56, issue.3, pp.270-274, 1963.
DOI : 10.1097/00007611-196303000-00008

W. Green, J. Bennett, and R. Goos, Ocular Penetration of Amphotericin B, Archives of Ophthalmology, vol.73, issue.6, pp.769-75, 1965.
DOI : 10.1001/archopht.1965.00970030771004

R. Arthur, R. Drew, and J. Perfect, Novel modes of antifungal drug administration, Expert Opinion on Investigational Drugs, vol.403, issue.7, pp.903-935, 2004.
DOI : 10.1016/S0883-5403(98)90086-9

A. Lotery, J. Kerr, and B. Page, Fungal keratitis caused by Scopulariopsis brevicaulis: successful treatment with topical amphotericin B and chloramphenicol without the need for surgical debridement., British Journal of Ophthalmology, vol.78, issue.9, p.730, 1994.
DOI : 10.1136/bjo.78.9.730

S. Bhomaj, J. Das, Z. Chaudhuri, R. Bansal, and P. Sharma, Rhinosporidiosis and peripheral keratitis, Ophthalmic Surg Lasers, vol.32, issue.4, pp.338-378, 2001.

R. Mahdy, W. Nada, and M. Wageh, Topical Amphotericin B and Subconjunctival Injection of Fluconazole (Combination Therapy) Versus Topical Amphotericin B (Monotherapy) in Treatment of Keratomycosis, Journal of Ocular Pharmacology and Therapeutics, vol.26, issue.3, pp.281-286, 2010.
DOI : 10.1089/jop.2010.0005

S. Ebrahim, G. Peyman, and P. Lee, Applications of Liposomes in Ophthalmology, Survey of Ophthalmology, vol.50, issue.2, pp.167-82, 2005.
DOI : 10.1016/j.survophthal.2004.12.006

U. Pleyer, J. Grammer, J. Pleyer, P. Kosmidis, D. Friess et al., Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B]. Ophthalmologe, pp.469-75, 1995.

L. Trissel, Handbook on injectable drugs, 2011.

J. Hecq, Centralized intravenous additive services (CIVAS): The state of the art in 2010, Annales Pharmaceutiques Fran??aises, vol.69, issue.1, pp.30-37, 2011.
DOI : 10.1016/j.pharma.2010.09.002

R. Rowe, P. Sheskey, and M. Quinn, Handbook of pharmaceutical excipients. London; Chicago, 2009.

. Calbiochem, Fiche de données de sécurité de l'amphotéricine B. [cité le 18 juill, Consulté sur, 2012.

. Stabilis, Monographie sur la stabilité de l'amphotéricine B liposomale, Consulté sur

S. Cardine, T. Bourcier, C. Chaumeil, O. Zamfir, V. Borderie et al., Prise en charge clinique et pronostic des kératites amibiennes: etude rétrospective à propos de 25 cas, J Fr Ophtalmol déc, vol.25, issue.10, pp.1007-1020, 2002.

C. Illingworth and S. Cook, Acanthamoeba Keratitis, Survey of Ophthalmology, vol.42, issue.6, pp.493-508, 1998.
DOI : 10.1016/S0039-6257(98)00004-6

T. Bourcier, Infections cornéennes: diagnostic et traitement, 2004.

C. Sotelo-avila, F. Taylor, and C. Ewing, Primary amebic meningoencephalitis in a healthy 7-year-old boy, The Journal of Pediatrics, vol.85, issue.1, pp.131-137, 1974.
DOI : 10.1016/S0022-3476(74)80309-4

M. Montserrat, M. Bazard, N. Commmun, and M. Labrude, Traitement de la kératite amibienne: étude de cas cliniques observés au CHU de Nancy, J Pharm Clin, vol.28, issue.1, pp.27-32, 2009.

T. Bourcier and C. Chaumeil, Prescrire les collyres antifongiques et antiamibiens, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.431-436, 2007.
DOI : 10.1016/S0181-5512(07)89619-7

D. Seal, Acanthamoeba keratitis update???incidence, molecular epidemiology and new drugs for treatment, Eye, vol.17, issue.8, pp.893-905, 2003.
DOI : 10.1038/sj.eye.6700563

M. Husson, Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67

M. Elder, S. Kilvington, and J. Dart, A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis, Invest. Ophthalmol. Vis. Sci, vol.35, issue.3, pp.1059-64, 1994.

C. Debbasch, C. Chaumeil, S. Quesnot, L. Batellier, and Y. Scat, Amebicide activity of antiseptics and an antibiotic on 2 Acanthamoeba isolated from corneal ulcers], J Fr Ophtalmol oct, vol.21, issue.8, pp.577-82, 1998.

S. Bourges and J. , Amibes et lentilles cornéennes, Consulté sur, 2012.

A. Azuara-blanco, A. Sadiq, M. Hussain, J. Lloyd, and H. Dua, Successful medical treatment of Acanthamoeba keratitis, International Ophthalmology, vol.21, issue.4, pp.223-230, 19971998.
DOI : 10.1023/A:1006055918101

J. Dart, V. Saw, and S. Kilvington, Acanthamoeba Keratitis: Diagnosis and Treatment Update 2009, American Journal of Ophthalmology, vol.148, issue.4, pp.487-499, 2009.
DOI : 10.1016/j.ajo.2009.06.009

A. Bacon, D. Frazer, J. Dart, M. Matheson, L. Ficker et al., A review of 72 consecutive cases of Acanthamoeba keratitis, 1984???1992, Eye, vol.34, issue.6, pp.719-744, 1984.
DOI : 10.1007/BF00927262

D. Larkin, S. Kilvington, and J. Dart, Treatment of Acanthamoeba Keratitis with Polyhexamethylene Biguanide, Ophthalmology, vol.99, issue.2, pp.185-91, 1992.
DOI : 10.1016/S0161-6420(92)31994-3

N. Lim, D. Goh, C. Bunce, W. Xing, G. Fraenkel et al., Comparison of Polyhexamethylene Biguanide and Chlorhexidine as Monotherapy Agents in the Treatment of Acanthamoeba Keratitis, American Journal of Ophthalmology, vol.145, issue.1, pp.130-135, 2008.
DOI : 10.1016/j.ajo.2007.08.040

D. Seal, J. Hay, C. Kirkness, A. Morrell, A. Booth et al., Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine, Eye, vol.8, issue.95, pp.413-434, 1996.
DOI : 10.1016/0035-9203(95)90429-8

M. Brandely-piat, C. Cadot, J. Bourges, and F. Chast, Kératites amibiennes: rôles du pharmacien d'officine et du pharmacien hospitalier dans la prévention et le traitement, J Pharm Clin sept, vol.30, issue.3, pp.129-164, 2011.

C. Van-haecke, M. Deprez, and B. Duchesne, Kératite à Acanthamoeba chez les porteurs de lentilles de contact: discussion et traitement. Pharmakon, janv, vol.35, issue.1, pp.10-13, 2003.

A. Lucas, E. Gordon, and M. Stratmeyer, Analysis of polyhexamethylene biguanide in multipurpose contact lens solutions???, Talanta, vol.80, issue.2, pp.1016-1025, 2009.
DOI : 10.1016/j.talanta.2009.07.031

L. Lim, D. Coster, and P. Badenoch, Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba, Clinical and Experimental Ophthalmology, vol.27, issue.2, pp.119-143, 2000.
DOI : 10.1145/256157.256160

M. Elder and J. Dart, Chemotherapy for acanthamoeba keratitis. Lancet. 1995 mars 25, pp.791-792

R. Rowe, P. Sheskey, and M. Quinn, Handbook of pharmaceutical excipients. London; Chicago, 2009.